TSVT

2seventy bio, Inc. (TSVT) Risks & Opportunities Analysis (2026)

Invetso Score: 5.7/10 — Balanced · Last Updated: 2026-08-01

Opportunities

Strong Liquidity Position: TSVT maintains a high current and quick ratio of 4.7, indicating robust liquidity and flexibility to fund operations and invest in growth initiatives relative to peers in the sector.

Negative Net Debt: The company’s net debt to EBITDA ratio is -1.8, reflecting a net cash position. This provides a buffer for strategic investments, R&D, or potential acquisitions without immediate financing constraints.

Potential for Operational Improvement: TSVT’s long cash conversion cycle and high days sales outstanding suggest significant room for working capital optimization, which could unlock cash flow and improve margins if addressed effectively.

TSVT’s strong liquidity and net cash position provide a solid foundation for financial flexibility and future investment. While current operational efficiency lags, this also presents an opportunity for management to drive margin and cash flow improvements through better working capital management.

Risks

Weak Interest Coverage: The company reports an interest coverage ratio of zero, indicating that current operating earnings are insufficient to cover interest expenses, which could signal near-term earnings pressure or reliance on non-operating cash to service debt.

High Debt-to-Equity Ratio: A debt-to-equity ratio of 1.16 is elevated versus many peers, increasing financial risk and potentially constraining future borrowing capacity if profitability does not improve.

Inefficient Working Capital Management: A cash conversion cycle of 58 days and days sales outstanding of 75 days remain elevated, tying up capital and increasing exposure to credit risk and delayed cash inflows.

TSVT faces material risks from weak interest coverage and high leverage, which could limit financial flexibility if operating performance does not improve. Inefficient working capital management further constrains cash flow and heightens credit risk.

Overall Score

TSVT’s strong liquidity and net cash position are offset by high leverage, weak interest coverage, and operational inefficiencies. The company’s ability to improve working capital and generate sustainable operating earnings will be critical to reducing risk and unlocking value. Current fundamentals place TSVT in a transition phase, with moderate opportunity but elevated risk relative to peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on 2seventy bio, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →